Cargando…

parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism

BACKGROUND: parkin mutations are a common cause of parkinsonism. Possessing two parkin mutations leads to early-onset parkinsonism, while having one mutation may predispose to late-onset disease. This dosage pattern suggests that some parkin families should exhibit intergenerational variation in age...

Descripción completa

Detalles Bibliográficos
Autores principales: Poorkaj, Parvoneh, Moses, Lina, Montimurro, Jennifer S, Nutt, John G, Schellenberg, Gerard D, Payami, Haydeh
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551608/
https://www.ncbi.nlm.nih.gov/pubmed/15725358
http://dx.doi.org/10.1186/1471-2377-5-4
_version_ 1782122472917696512
author Poorkaj, Parvoneh
Moses, Lina
Montimurro, Jennifer S
Nutt, John G
Schellenberg, Gerard D
Payami, Haydeh
author_facet Poorkaj, Parvoneh
Moses, Lina
Montimurro, Jennifer S
Nutt, John G
Schellenberg, Gerard D
Payami, Haydeh
author_sort Poorkaj, Parvoneh
collection PubMed
description BACKGROUND: parkin mutations are a common cause of parkinsonism. Possessing two parkin mutations leads to early-onset parkinsonism, while having one mutation may predispose to late-onset disease. This dosage pattern suggests that some parkin families should exhibit intergenerational variation in age at onset resembling anticipation. A subset of familial PD exhibits anticipation, the cause of which is unknown. The aim of this study was to determine if anticipation was due to parkin mutation dosage. METHODS: We studied 19 kindreds that had early-onset parkinsonism in the offspring generation, late-onset parkinsonism in the parent generation, and ≥ 20 years of anticipation. We also studied 28 early-onset parkinsonism cases without anticipation. Patients were diagnosed by neurologists at a movement disorder clinic. parkin analysis included sequencing and dosage analysis of all 12 exons. RESULTS: Only one of 19 cases had compound parkin mutations, but contrary to our postulate, the affected relative with late-onset parkinsonism did not have a parkin mutation. In effect, none of the anticipation cases could be attributed to parkin. In contrast, 21% of early-onset parkinsonism patients without anticipation had parkin mutations. CONCLUSION: Anticipation is not linked to parkin, and may signify a distinct disease entity.
format Text
id pubmed-551608
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5516082005-03-04 parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism Poorkaj, Parvoneh Moses, Lina Montimurro, Jennifer S Nutt, John G Schellenberg, Gerard D Payami, Haydeh BMC Neurol Research Article BACKGROUND: parkin mutations are a common cause of parkinsonism. Possessing two parkin mutations leads to early-onset parkinsonism, while having one mutation may predispose to late-onset disease. This dosage pattern suggests that some parkin families should exhibit intergenerational variation in age at onset resembling anticipation. A subset of familial PD exhibits anticipation, the cause of which is unknown. The aim of this study was to determine if anticipation was due to parkin mutation dosage. METHODS: We studied 19 kindreds that had early-onset parkinsonism in the offspring generation, late-onset parkinsonism in the parent generation, and ≥ 20 years of anticipation. We also studied 28 early-onset parkinsonism cases without anticipation. Patients were diagnosed by neurologists at a movement disorder clinic. parkin analysis included sequencing and dosage analysis of all 12 exons. RESULTS: Only one of 19 cases had compound parkin mutations, but contrary to our postulate, the affected relative with late-onset parkinsonism did not have a parkin mutation. In effect, none of the anticipation cases could be attributed to parkin. In contrast, 21% of early-onset parkinsonism patients without anticipation had parkin mutations. CONCLUSION: Anticipation is not linked to parkin, and may signify a distinct disease entity. BioMed Central 2005-02-22 /pmc/articles/PMC551608/ /pubmed/15725358 http://dx.doi.org/10.1186/1471-2377-5-4 Text en Copyright © 2005 Poorkaj et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Poorkaj, Parvoneh
Moses, Lina
Montimurro, Jennifer S
Nutt, John G
Schellenberg, Gerard D
Payami, Haydeh
parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism
title parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism
title_full parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism
title_fullStr parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism
title_full_unstemmed parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism
title_short parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism
title_sort parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551608/
https://www.ncbi.nlm.nih.gov/pubmed/15725358
http://dx.doi.org/10.1186/1471-2377-5-4
work_keys_str_mv AT poorkajparvoneh parkinmutationdosageandthephenomenonofanticipationamoleculargeneticstudyoffamilialparkinsonism
AT moseslina parkinmutationdosageandthephenomenonofanticipationamoleculargeneticstudyoffamilialparkinsonism
AT montimurrojennifers parkinmutationdosageandthephenomenonofanticipationamoleculargeneticstudyoffamilialparkinsonism
AT nuttjohng parkinmutationdosageandthephenomenonofanticipationamoleculargeneticstudyoffamilialparkinsonism
AT schellenberggerardd parkinmutationdosageandthephenomenonofanticipationamoleculargeneticstudyoffamilialparkinsonism
AT payamihaydeh parkinmutationdosageandthephenomenonofanticipationamoleculargeneticstudyoffamilialparkinsonism